RxDoctor Payments Data

Jacob West, MD

Family Medicine · Ventura, CANPI 1154815991

Payments from drug & device makers

$815in general payments, 2019–2025

Across 38 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$148
  • AstraZeneca$90
  • Dexcom, Inc.$79
  • Radius Health, Inc.$70
  • Amgen$46
  • GSK$44
  • plus $339 from 13 others

What the payments were for

  • Food & beverage$815100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$815 in reported general payments places this provider in the 70th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$123,252
Medicare patients
379
Services billed
1,348

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$64,729
OzempicSemaglutide41$63,400
JardianceEmpagliflozin33$47,656
JanuviaSitagliptin Phosphate34$38,710
MounjaroTirzepatide17$26,244
XareltoRivaroxaban28$24,735
TrulicityDulaglutide21$23,955
Tresiba Flextouch U-100Insulin Degludec14$22,435
MyrbetriqMirabegron15$15,737
JanumetSitagliptin Phos/Metformin Hcl22$13,606
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$12,198
Repatha SureclickEvolocumab11$11,938
Spiriva HandihalerTiotropium Bromide12$5,532
Atorvastatin Calcium557$5,056
Fluticasone-SalmeterolFluticasone Propion/Salmeterol25$4,876

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$42$64,72956 claims
Novo NordiskOzempic$36$63,40041 claims
MerckJanuvia, Janumet$21$52,31656 claims
Lilly USA, LLCMounjaro, Trulicity$42$50,20038 claims
Boehringer IngelheimJardiance$22$47,65633 claims
GSKTrelegy Ellipta$44$12,19816 claims
AbbVieSynthroid$19$1,46934 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,533 family medicine providers in California.

Other family medicine in Ventura

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →